Company Overview and News

60
A Cheap Valuation and Strong Dividend Make IBM Stock Worth the Wait

2h investorplace
It’s been a reasonably frustrating 2018 for IBM (NYSE:IBM). IBM stock has declined almost 5% so far this year, despite some good news.
IBM GE F GEC AMZN GOOGL GNE MSFT GOOG INTC CRM ORCL

16
Lithium Americas Strengthens Senior Management Team, Appoints President and Chief Operating Officer

6h globenewswire
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) ("Lithium Americas" or the "Company"), is pleased to announce new appointments to the senior management team following the recently announced strategic transaction with Jiangxi Ganfeng Lithium Co. Ltd. (“Ganfeng Lithium”) to jointly advance the Cauchari-Olaroz lithium project in Jujuy, Argentina (“Cauchari-Olaroz”), in addition to the Company’s continuing development of the 100%-owned Thacker Pass lithium project in Nevada, USA (“Thacker Pass”).
GEC GE FTI.WI FMC DTK LACDF GNE LAC

17
General Electric Hits A New Low - What Now?

6h seekingalpha
The company plans to reshape its portfolio significantly, and has planned spin-offs. I view asset sales as a positive.
BHI GEC GE SIEGY GNE UTX

58
Why Apple Stock May Fall Victim to the Winner’s Curse

8h investorplace
Apple (NASDAQ:AAPL) recently made stock market history. It beat all the challengers, topping Amazon (NASDAQ:AMZN), Alphabet (NASDAQ:GOOGL, NASDAQ:GOOG), and other potential rivals to the crown. The prize? AAPL stock recently became the first equity in American history to sport a market capitalization of $1 trillion.
IBM GE GEC AMZN XOM GOOGL AAPL GNE GOOG

25
3 Pros, 3 Cons for Beleaguered General Electric Stock

8h investorplace
Last week, General Electric Company (NYSE:GE) hit a terrible milestone. The shares broke below $12, which was the lowest since the depths of the financial crisis in 2009. The market value on General Electric stock is now at $107 billion.
BHI GE GEC BHGE GNE UTX SYF

15
GE's Bet On Neuronetics: Sell It At 8.32x Forward Sales

8h seekingalpha
Neuronetics, Inc. is a medical technology company marketing a system designed to treat adult patients with major depressive disorder.
GEC GE GNE BRSYF

17
A Rediscovered Masterpiece by Benjamin Graham | Jason Zweig

11h jasonzweig
Here is the speech Benjamin Graham gave in San Francisco one week before John F. Kennedy was assassinated. In this brilliant presentation, Graham explores how an investor should go about determining whether the market is overvalued, how to tell which asset allocation is right for you, and how to pick stocks wisely. This speech is a rare opportunity to see the workings of Graham’s mind in the raw.
IBM GEC GE DOW DTK GNE

64
5 Reasons Why Ford Will End Up Cutting Its Dividend

13h seekingalpha
Ford is a recognizable name with a juicy dividend that yields more than 6%. This makes it an appetizing stock for dividend investors.
GEC GE TSLA GNE

16
With GE Stock at Nine Year Lows, Is It Time to Buy the Dip?

2018-08-20 investorplace - 1
Industrial conglomerate General Electric (NYSE:GE) made headlines again this week — and not in a good way. GE stock dropped below $12 for the first time since July 2009. To put that in perspective, GE stock was a $30-plus stock at the beginning of last year.
GE GEC GNE

21
General Electric: How I Currently View This Beaten Down Conglomerate

2018-08-20 seekingalpha - 2
The company still has a long way to go, but its management team is doing what is necessary to right the ship.
GEC GE GNE SYF

16
Paul Singer, Doomsday Investor | The New Yorker

2018-08-20 newyorker
Singer, through his hedge fund, Elliott Management, has developed a unique, and profitable, brand of adversarial investing.
GEC GE CZR GNE

15
Apple and other stocks have contributed the most to this bull market

2018-08-20 cnbc
Stocks have surged more than 300 percent during this historic bull market thanks in large part to Apple.
GEC GE GNE

53
Forget $1 Trillion, AMZN Will Hit $2 Trillion by This Date

2018-08-20 investorplace
Wondering when Amazon (NASDAQ:AMZN) is going to hit $1 trillion is so 1980s. Just $90 billion away from $1 and nine zeros, AMZN stock needs to increase $184 or 9.8% to become only the second public company to hit the exclusive market cap.
BRK.A GE GEC AMZN GNE NYTAB

15
Mentor Capital, Inc. Chairman and CEO, Chet Billingsley, Discusses Exciting Company Growth with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

2018-08-20 globenewswire
PHOENIX, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Mentor Capital, Inc., just uplisted recently with their ticker symbol now at OTCQX:MNTR.
MNTR GEC GE GNE

19
General Electric: Headed For Single Digits?

2018-08-19 seekingalpha
General Electric has presented a restructuring plan earlier this year that includes asset sales, cost cuts and a business repositioning. However, it will take time for shareholders to see results.
HON BHI GEC GE MTSI HON GNE

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...